Waldenstrom macroglobulinemia: prognosis and management

by Oza, A, Rajkumar, S V
Published 2016

Waldenstrom macroglobulinemia: prognosis and management

by Oza, A, Rajkumar, S V
Published 2015

Optimal chemotherapy treatment for women with recurrent ovarian cancer

by Fung-Kee-Fung, M., Oliver, T., Elit, L., Oza, A., Hirte, H.W., Bryson, P.
Published 2007

2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.

by Hickish, T., Serafinowski, P., Cunningham, D., Oza, A., Dorland, E., Judson, I., Millar, B. C., Lister, T. A., Roldan, A.
Published 1993

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients

by Wilbaux, M, Hénin, E, Oza, A, Colomban, O, Pujade-Lauraine, E, Freyer, G, Tod, M, You, B
Published 2014

Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.

by Oza, A. M., Ganesan, T. S., Dorreen, M., Johnson, P. W., Waxman, J., Gregory, W., Lim, J., Wright, J., Dadiotis, L., Barbounis, V.
Published 1992

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.

by Rohatiner, A. Z., Bassan, R., Battista, R., Barnett, M. J., Gregory, W., Lim, J., Amess, J., Oza, A., Barbui, T., Horton, M.
Published 1990

A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium

by Lheureux, S, Oza, A M, Laurie, S A, Halford, R, Jonker, D, Chen, E, Keller, D, Bourade, V, Wang, L, Doyle, L, Siu, L L, Goel, R
Published 2015

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

by Sahebjam, S, Bedard, P L, Castonguay, V, Chen, Z, Reedijk, M, Liu, G, Cohen, B, Zhang, W-J, Clarke, B, Zhang, T, Kamel-Reid, S, Chen, H, Ivy, S P, Razak, A R A, Oza, A M, Chen, E X, Hirte, H W, McGarrity, A, Wang, L, Siu, L L, Hotte, S J
Published 2013

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consort...

by Köbel, M, Madore, J, Ramus, S J, Clarke, B A, Pharoah, P D P, Deen, S, Bowtell, D D, Odunsi, K, Menon, U, Morrison, C, Lele, S, Bshara, W, Sucheston, L, Beckmann, M W, Hein, A, Thiel, F C, Hartmann, A, Wachter, D L, Anglesio, M S, Høgdall, E, Jensen, A, Høgdall, C, Kalli, K R, Fridley, B L, Keeney, G L, Fogarty, Z C, Vierkant, R A, Liu, S, Cho, S, Nelson, G, Ghatage, P, Gentry-Maharaj, A, Gayther, S A, Benjamin, E, Widschwendter, M, Intermaggio, M P, Rosen, B, Bernardini, M Q, Mackay, H, Oza, A, Shaw, P, Jimenez-Linan, M, Driver, K E, Alsop, J, Mack, M, Koziak, J M, Steed, H, Ewanowich, C, DeFazio, A, Chenevix-Trench, G, Fereday, S, Gao, B, Johnatty, S E, George, J, Galletta, L, Goode, E L, Kjær, S K, Huntsman, D G, Fasching, P A, Moysich, K B, Brenton, J D, Kelemen, L E
Published 2014